Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0950
-0.0031 (-3.16%)
Apr 1, 2025, 3:57 PM EST

PVCT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
425340452323
Upgrade
Market Cap Growth
30.64%30.64%-11.35%96.93%-1.55%-5.21%
Upgrade
Enterprise Value
455543482346
Upgrade
Last Close Price
0.100.120.100.110.060.06
Upgrade
PS Ratio
68.0385.2672.2145.94--
Upgrade
PB Ratio
-8.81-8.81-5.30-7.29-5.51-0.78
Upgrade
EV/Sales Ratio
72.7789.5177.2548.64--
Upgrade
Debt / Equity Ratio
-0.53-0.53-0.40-0.35-0.42-0.79
Upgrade
Asset Turnover
0.500.500.320.36--
Upgrade
Quick Ratio
0.040.040.010.000.090.00
Upgrade
Current Ratio
0.140.140.150.230.450.01
Upgrade
Return on Assets (ROA)
-230.29%-230.29%-89.58%-64.62%-141.40%-298.62%
Upgrade
Earnings Yield
-11.33%-9.05%-7.70%-7.82%-24.01%-28.50%
Upgrade
FCF Yield
-6.24%-6.24%-6.39%-6.69%-4.39%-17.44%
Upgrade
Buyback Yield / Dilution
-0.07%-0.07%-0.01%-2.76%-3.81%-1.72%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.